90% of U.S. adults are at risk of developing cardiovascular disease, yet 80% of premature cardiovascular diseases are preventable with early intervention. Biotricityโs remote cardiac monitoring solutions are bringing us closer to a preventative versus a reactive healthcare system. The companyโs advanced remote cardiac monitoring solutions offer data driven insights, allowing patients and providers to stay ahead of potential heart issues.
Heart disease is often referred to as the “silent killer” because its symptoms can be difficult to detect until it’s too late. In the United States alone, cardiovascular diseases account for nearly 700,000 deaths annually, making it the leading cause of death. For many, symptoms of heart disease can be easily overlooked and a delayed diagnosis can lead to serious complications, like a heart attack or stroke.
Managing heart health can often be overwhelming for patients and challenging for healthcare providers. Biotricity is filling gaps in healthcare accessibility and management with transformative solutions that deliver reliable insights into heart health. Their solutions make continuous heart monitoring easy, helping patients and providers address issues before they escalate.
Empowering Individuals & Medical Professionals: Providing Peace of Mind
Keeping track of your heartโs health shouldnโt be complicated. Whether youโre an athlete optimizing performance, or someone managing a heart condition, continuously monitoring, and understanding, your heart metrics can make all the difference. Biotricityโs remote cardiac monitoring solutions, including Biocore, Bioheart, and Biokit, provide data-driven insights. This helps individuals, patients, and healthcare providers stay ahead of potential issues. Biotricityโs solutions bring peace of mind and promote better health outcomes.
Continuous Monitoring: The Early Warning System You Need
Cardiologists typically manage dozens of patients with varying levels of risk simultaneously. Biotricityโs solutions can help improve operational efficiency so doctors can monitor multiple patients at once, receiving instant alerts when something requires attention.
Consider a patient diagnosed with atrial fibrillation (AFib), a condition which significantly increases risk of stroke. Alarmingly, a study in the Journal of the American College of Cardiology found that nearly 50% of AFib cases go undiagnosed. Biotricityโs Biocore changes this. Unlike traditional Holter monitors, which provide a limited snapshot over 24 to 48 hours, Biocore offers continuous monitoring for up to 30 days, transmitting data continuously to healthcare providers. Irregularities are flagged immediately, allowing healthcare providers to intervene quickly which reduces the risk of complications.
The market recognizes the value of such innovations. According to The Business Research Company, the wearable ECG monitor market is projected to reach $8.89 billion by 2028. Biotricity is leading this charge with devices like Biocore that go beyond fitness tracking, providing medical-grade accuracy and clinically relevant data.
How Biotricity Rises Above the Rest
Holter monitors have been the standard of care for decades, but their 24- to 48-hour recording window often fails to capture critical heart trends. Additionally, since Holter monitors require a physicianโs prescription, they are inaccessible to individuals who are asymptomatic or simply proactive about their heart health. While consumer wearables like smartwatches offer some monitoring capabilities, they are limited by user initiation, detect only a handful of arrhythmias, and lack the medical-grade precision needed for accurate diagnostics.
Biotricity bridges this gap with its consumer device, Bioheart. Bioheart uses the most advanced heart technology combined with powerful analytics and continuous rhythm monitoring with 3-views of your heart to deliver feedback needed to understand heart health. Bioheart syncs to users smartphones so they can view data and summaries on metrics like heart rate variability, through an integrated app for advanced health tracking.
A Look Ahead: The Future of Heart Health
Thereโs no doubt that heart health is entering a new era, driven by innovation. By 2033, the remote cardiac monitoring market is expected to reach $9.75 billion, growing at an annual rate of over 11%. And itโs easy to see why. Biotricityโs remote cardiac monitoring solutions are making heart care more proactive, shifting from reactive treatments to early interventions. For patients, this means fewer hospital visits, reduced stress, and an overall higher quality of life. For healthcare providers, it means better outcomes and smarter resource allocation. For more on Biotricityโs life-changing innovations, visit biotricity.com.
